Clinical TrialsSearch results
Number of results: 62426
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Not yet recruiting
- A study to test how well different doses of BI 3706674 are tolerated by people with advanced cancer in the stomach and oesophagus
- GAC, EAC, and GEJAC solid tumours with KRAS wt amplification, Solid tumours of any histology
- Kurei Katsutoshi
- 2023-09-12
Not yet recruiting
- A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Candin (Candida albicans Skin Test Antigen for Cellular Hypersensitivity) for the Treatment of Common Warts (Verruca vulgaris) in Adolescents and Adults (CFW-3A)
- Common Warts (Verruca vulgaris)
- Kanmuri Kazuhiro
- 2023-09-12
Recruiting
- Salt and trace element balance during exercise in hot and humid environments.
- Heat related illness
- kAKAMU Takeyasu
- 2023-09-12
Recruiting
- Investigator-initiated clinical trial of bradycardia with transvenous vagus nerve stimulation catheters for supraventricular tachyarrhythmias
- Atrial fibrillation/Atrial flutter/Atrial tachycardia etc.
- Sakamoto Kazuo
- 2023-09-12
Recruiting
- Electrocautery ablation of high-grade anal intraepithelial lesions
- Anal intraepithelial neoplasia
- Ando Naokatsu
- 2023-09-12
Recruiting
- A study on the effects of diet in the ICU
- heart failure.acute coronary syndrome
- Megumi Tani
- 2023-09-12
Recruiting
- A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation
- Advanced/metastatic NSCLC with Exon 20 insertions and Uncommon/Single or Compound EGFR Mutations
- Wacheck Volker
- 2023-09-12
Recruiting
- A Study of Zipalertinib and Chemotherapy Compared With Chemotherapy Alone in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion
- Locally advanced or metastatic nonsquamous NSCLC harboring EGFR exon 20 insertion mutations
- Wacheck Volker
- 2023-09-12
Recruiting
- A multiple-ascending dose study of RO7126209 in patients with prodromal or mild to moderate Alzheimer's disease
- Alzheimer's disease
- Luka Kulic MD
- 2023-09-12
Recruiting
- NCGG401-AD
- Alzheimer's disease Temporal lobe epilepsy Glioma
- Kimura Yasuyuki
- 2023-09-11